open access

Vol 1, No 2 (2012)
Research paper
Submitted: 2012-06-01
Accepted: 2012-06-01
Published online: 2012-06-01
Get Citation

Prevalence of hyperfiltration in type 2 diabetes patients

Konrad Walczak, Irmina Korzeniewska-Dyl, Anna Krysicka, Małgorzata Sodolska, Dariusz Moczulski
Diabetologia Kliniczna 2012;1(2):49-54.

open access

Vol 1, No 2 (2012)
Original articles
Submitted: 2012-06-01
Accepted: 2012-06-01
Published online: 2012-06-01

Abstract

Background. The role of hyperfiltration in thepathomechanism of diabetic kidney disease has notbeen well explained. The aim of this study was todetermine the prevalence of hyperfiltration in patientswith type 2 diabetes. The association betweenhyperfiltration and clinical parameters were analyzed.

Material and methods. 150 patients with type 2diabetes and eGFR > 60 ml/min/1.73 m2 wereexamined. Serum cystatin C concentration wasassessed in each patients and glomerular filtrationrate (eGFR) was estimated. Hyperfiltration was defineas eGFR > 134 ml/min/1.73 m2 in men and eGFR> 149 ml/min/1.73 m2 in women.

Results. Hyperfiltration was present in 20 (13.3%) of150 analyzed patients. Hyperfiltration was found in 9 women and 11 men. There was no difference between patient with and without hyperfiltrationaccording to concentration of potassium,triglycerides, total cholesterol and CRP. Also, urinaryalbumin excretion in both groups did not differ fromeach other. People with hyperfiltration had a shorterduration of diabetes from diagnosis and wereyounger. Patients with hyperfiltration had higherHbA1c and lower BMI than subjects withouthyperfiltration. Hyperfiltration was less frequent inpatients taking inhibitors of angiotensin convertingenzyme (ACEI) and angiotensin II receptor blockers(ARB).

Conclusions. Hyperfiltration is rare in patients withtype 2 diabetes. Poor glycemic control increases riskof hyperfiltration, but age and BMI dicrease the risk.Hyperfiltration is less frequently in patients takingACEI and ARB.

Abstract

Background. The role of hyperfiltration in thepathomechanism of diabetic kidney disease has notbeen well explained. The aim of this study was todetermine the prevalence of hyperfiltration in patientswith type 2 diabetes. The association betweenhyperfiltration and clinical parameters were analyzed.

Material and methods. 150 patients with type 2diabetes and eGFR > 60 ml/min/1.73 m2 wereexamined. Serum cystatin C concentration wasassessed in each patients and glomerular filtrationrate (eGFR) was estimated. Hyperfiltration was defineas eGFR > 134 ml/min/1.73 m2 in men and eGFR> 149 ml/min/1.73 m2 in women.

Results. Hyperfiltration was present in 20 (13.3%) of150 analyzed patients. Hyperfiltration was found in 9 women and 11 men. There was no difference between patient with and without hyperfiltrationaccording to concentration of potassium,triglycerides, total cholesterol and CRP. Also, urinaryalbumin excretion in both groups did not differ fromeach other. People with hyperfiltration had a shorterduration of diabetes from diagnosis and wereyounger. Patients with hyperfiltration had higherHbA1c and lower BMI than subjects withouthyperfiltration. Hyperfiltration was less frequent inpatients taking inhibitors of angiotensin convertingenzyme (ACEI) and angiotensin II receptor blockers(ARB).

Conclusions. Hyperfiltration is rare in patients withtype 2 diabetes. Poor glycemic control increases riskof hyperfiltration, but age and BMI dicrease the risk.Hyperfiltration is less frequently in patients takingACEI and ARB.

Get Citation

Keywords

type 2 diabetes, hyperfiltration, body mass index, HBA1c, hypertension, ACEI, ARB

About this article
Title

Prevalence of hyperfiltration in type 2 diabetes patients

Journal

Clinical Diabetology

Issue

Vol 1, No 2 (2012)

Article type

Research paper

Pages

49-54

Published online

2012-06-01

Page views

780

Article views/downloads

2562

Bibliographic record

Diabetologia Kliniczna 2012;1(2):49-54.

Keywords

type 2 diabetes
hyperfiltration
body mass index
HBA1c
hypertension
ACEI
ARB

Authors

Konrad Walczak
Irmina Korzeniewska-Dyl
Anna Krysicka
Małgorzata Sodolska
Dariusz Moczulski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl